CCS Consults on the Proposed Acquisition by Texas Instruments Incorporated of Silicon Laboratories Inc.
9 July 2026
1. The Competition and Consumer Commission of Singapore (“CCS”) is inviting public feedback on the proposed acquisition by Texas Instruments Incorporated (“TI”) of 100% of the issued and outstanding shares of Silicon Laboratories Inc (“Silicon Labs”) (collectively, the “Parties”) (the “Proposed Transaction”).
2. CCS accepted a joint application from the Parties on 3 July 2026 for a decision on the Proposed Transaction. CCS is now assessing whether the Proposed Transaction may result in a substantial lessening of competition within any market in Singapore.
The Parties
TI
3. TI is a public company listed on the Nasdaq Global Select Market (“Nasdaq”). It is a global semiconductor company that designs, manufactures, and sells analog and embedded processing chips to electronics designers and manufacturers all over the world. The global activities of TI, together with all its subsidiaries, extend to, and include Singapore.
Silicon Labs
4. Silicon Labs is a public company listed on the Nasdaq. It is a U.S.-headquartered fabless semiconductor group that primarily designs and develops wireless connectivity solutions with integrated system-on-chips (“SoCs”). Silicon Labs does not own or operate fabrication facilities and engages in design, sales, and customer support related activities worldwide. The global activities of Silicon Labs, together with all its subsidiaries, extend to, and include Singapore.
The Proposed Transaction
5. The Parties submitted that the relevant product markets for the purpose of this notification are the global supply of:
a. Wireless connectivity SoCs;
b. Non-wireless microcontroller units;
c. Power management integrated circuits;
d. Sensors; and
e. Universal serial bus bridges
(the “Relevant Markets”).
6. The Parties submitted that the Proposed Transaction will not give rise to any non-coordinated or coordinated effects in each of the Relevant Markets in view of the following:
a. Non-coordinated effects
i. The Parties are modest players in a fragmented global market, with many significant competitors;
ii. The Parties’ customers, typically large and sophisticated companies, are able to switch and mix between different suppliers and negotiate against the behaviour of their service providers;
iii. There are low barriers to entry and expansion; and
iv. The Parties are not close competitors in the Relevant Markets and their activities are complementary.
b. Coordinated effects
i. Each of the Relevant Markets will remain extremely competitive with the presence of a multitude and range of existing competitors of varying scales of operations;
ii. Suppliers of semiconductor products across all the Relevant Markets compete on the basis of product differentiation and are constantly innovating to offer new and improved products on the market;
iii. Pricing of semiconductor products across all the Relevant Markets is typically negotiated on an individual basis and is based on a variety of pricing models; and
iv. Customers generally have the knowledge and expertise to make well-informed comparisons of alternatives available on the market, which facilitates the process of switching between different suppliers in response to price changes or any other reason.
7. The Parties also submitted that the Proposed Transaction would not give rise to any vertical effects, as it only affects a few very limited potential or actual supply relationships between the Parties. No conglomerate effects are anticipated either, as neither Party currently bundles nor ties its products. The Proposed Transaction would not give TI the ability or incentive to pursue such a strategy.
Public Consultation
8. CCS is inviting public feedback on the Proposed Transaction. The closing date for submissions is 22 July 2026, 5 p.m.
9. More information on this public consultation can be accessed and downloaded from the CCS website at www.ccs.gov.sg under the section “Public Consultation”. If any submission or correspondence in response to this public consultation contains confidential information, please also provide CCS with a non-confidential version of the submission or correspondence.
